- Home
- PSQH vs ANL Comparison
PSQH vs ANL Comparison
Compare PSQH & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSQH
- ANL
- Stock Information
- Founded
- PSQH 2021
- ANL 2004
- Country
- PSQH United States
- ANL Cayman Islands
- Employees
- PSQH N/A
- ANL N/A
- Industry
- PSQH Advertising
- ANL
- Sector
- PSQH Consumer Discretionary
- ANL
- Exchange
- PSQH Nasdaq
- ANL Nasdaq
- Market Cap
- PSQH 75.3M
- ANL 79.0M
- IPO Year
- PSQH N/A
- ANL 2023
- Fundamental
- Price
- PSQH $4.64
- ANL $2.05
- Analyst Decision
- PSQH Strong Buy
- ANL Strong Buy
- Analyst Count
- PSQH 2
- ANL 2
- Target Price
- PSQH $5.75
- ANL $9.00
- AVG Volume (30 Days)
- PSQH 1.8M
- ANL 13.8K
- Earning Date
- PSQH 03-13-2025
- ANL 02-24-2025
- Dividend Yield
- PSQH N/A
- ANL N/A
- EPS Growth
- PSQH N/A
- ANL N/A
- EPS
- PSQH N/A
- ANL N/A
- Revenue
- PSQH $18,738,575.00
- ANL $5,000,000.00
- Revenue This Year
- PSQH $320.53
- ANL N/A
- Revenue Next Year
- PSQH $56.41
- ANL N/A
- P/E Ratio
- PSQH N/A
- ANL N/A
- Revenue Growth
- PSQH 482.62
- ANL N/A
- 52 Week Low
- PSQH $2.00
- ANL $1.85
- 52 Week High
- PSQH $7.77
- ANL $17.48
- Technical
- Relative Strength Index (RSI)
- PSQH 57.59
- ANL 44.92
- Support Level
- PSQH $3.58
- ANL $2.00
- Resistance Level
- PSQH $4.90
- ANL $2.19
- Average True Range (ATR)
- PSQH 0.50
- ANL 0.27
- MACD
- PSQH -0.03
- ANL -0.01
- Stochastic Oscillator
- PSQH 66.25
- ANL 16.81
About PSQH PSQ Holdings Inc.
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. The primary mission of the platform is to help consumers "shop their values" and put purpose behind purchases. It has two reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.